COVID-19 Fundamentals: What We Know

Released On
July 31, 2020

Expires On
July 31, 2021

Media Type

Completion Time
30 minutes

Scroll to the Bottom of this Information to Begin this Course

Credit Available

  • Physicians — maximum of 0.5 AMA PRA Category 1 Credit(s)
  • Nurses — 0.5 Nursing Contact Hours
  • Physicians Assistants — maximum of 0.5 AAPA Credits

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity is intended for health care providers in the care of patients with COVID-19.

Program Overview

In this program, Dr. Auwaerter discusses the basics of our understanding of COVID-19.

Learning Objectives

After completing this activity, the participant should be better able to:

  • Discuss epidemiological data pertaining to COVID-19.
  • Identify the most prevalent risk factors for increased disease severity.
  • Describe the implications of diagnostic and antibody testing challenges.
  • Evaluate current supportive and targeted treatments and those in development for COVID-19.
  • Describe experimental vaccines and the vaccine development process for COVID-19.


Paul G Auwaerter, MD, MBA, FIDSA

Paul G Auwaerter, MD, MBA, FIDSA

Past President of the Infectious Diseases Society of America (IDSA)
Professor of Medicine
Johns Hopkins University School of Medicine

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and DKBmed. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA Credit Designation Statement – Enduring Materials

The Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credits. Approval is valid until July 31, 2021. PAs should only claim credit commensurate with the extent of their participation.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.50 contact hours.

Credit Designation

This 0.50 contact hour educational activity is provided by the Institute for Johns Hopkins Nursing. Statements will be awarded for this educational activity July 31, 2021.

Disclosures of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

It is the policy of the Institute for Johns Hopkins Nursing that the presenter and provider globally disclose conflicts of interest. The IJHN has established policies that will identify and resolve conflicts of interest prior to this educational activity.

Faculty / Presenter Reported Financial Relationship

Paul G. Auwaerter, MD, MBA, FIDSA

  • Scientific Advisor: DiaSaorin, Shionogi Inc.
  • Ownership Equity: JNP

Planners and Managers

The PIM planners and managers have nothing to disclose. The DKBmed planners and managers have nothing to disclose. The IJHN Nurse Planner has nothing to disclose.

Instructions for Participation and Credit

There are no fees for participating and receiving CME/CE credit for this activity. During the period of July 31, 2020 through July 31, 2021, participants must read the learning objectives and faculty disclosures and study the educational activity. In order to receive nursing contact hours, participants must also complete and submit an evaluation.
If you wish to receive acknowledgment for completing this activity, please complete the evaluation.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

The opinions expressed in this educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.